Pharmaceutical Technology14h
$590m to Moderna from HHS for mRNA ‘flu vax development
Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...
Pharmaceutical Technology15h
KeyMed partners with US-based biotech Prolium in bispecific antibody deal
Investment company RTW Investments has launched a new biotech company called Prolium Bioscience, to advance the development ...
Pharmaceutical Technology15h
FDA’s START and CoGenT pilot programmes: Streamlining rare disease drug approvals
This week, at the J.P. Morgan Healthcare Conference and the Biotech Showcase, discussions underscored the growing focus on ...
Pharmaceutical Technology17h
Interleukin inhibitors remain a strong growth driver in dermatology
If the results from the clinical development plans are positive, it may well reflect a paradigm shift for clinical care.
Pharmaceutical Technology19h
Arrowhead’s plozasiran set for FDA review as Tryngolza challenge looms
An FDA approval later this year for Arrowhead’s plozasiran in FCS would put it in direct competition with Ionis’ Tryngolza.
Pharmaceutical Technology20h
Feinstein Institutes gains NIH grant to explore ghrelin for GI-ARS
Northwell Health’s Feinstein Institutes for Medical Research has received a $2.9m grant from the NIH to explore the use of ...
Pharmaceutical Technology22h
FDA approves Amgen’s combo therapy for colorectal cancer
Amgen’s LUMAKRAS and Vectibix combination has received approval from the US FDA for treating KRAS G12C-mutated mCRC.